n-(3-(aminomethyl)benzyl)acetamidine and arl 17477

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with arl 17477 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auguet, M; Chabrier, PE; Demerlé-Pallardy, C1
Bonnefont-Rousselot, D; Jafarian-Tehrani, M; Lerouet, D; Louin, G; Margaill, I; Palmier, B; Plotkine, M1

Reviews

1 review(s) available for n-(3-(aminomethyl)benzyl)acetamidine and arl 17477

ArticleYear
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.
    Cellular and molecular life sciences : CMLS, 1999, Volume: 55, Issue:8-9

    Topics: Alzheimer Disease; Amidines; Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Brain Injuries; Brain Ischemia; Enzyme Induction; Humans; Huntington Disease; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Nerve Degeneration; Nerve Tissue Proteins; Nervous System Diseases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Specificity; Polymethacrylic Acids; Pyrazines; Thiophenes

1999

Other Studies

1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and arl 17477

ArticleYear
Lack of iNOS induction in a severe model of transient focal cerebral ischemia in rats.
    Experimental neurology, 2005, Volume: 195, Issue:1

    Topics: Amidines; Analysis of Variance; Animals; Anticoagulants; Benzylamines; Blotting, Western; Brain; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Edetic Acid; Enzyme Inhibitors; Inhibitory Concentration 50; Ischemic Attack, Transient; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors

2005